Crossmark

Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-024-13052-5

Published Online: 2024-10-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cui, Manlu

Fu, Juan

Li, Qiuyun
License Information

Text and Data Mining valid from 2024-10-18

Version of Record valid from 2024-10-18
More Information

Article History

Received: 3 July 2024

Accepted: 10 October 2024

First Online: 18 October 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below